CD274 and lung cancer: An inhibitor of α-mannosidase, namely, swainsonine, was reported to interrupt PD-L1 N-glycosylation, and the combination of swainsonine and anti-PD-L1 exerted a synergistic therapeutic effect on lung cancer and melanoma [112].